A subgroup analysis of the phase 3 FOCUS study (NCT02678572) shows that the Melphalan/Hepatic Delivery System (HDS; HEPZATO ...

Ultrasound-derived VAT demonstrated better predictive ability than BMI and waist circumference in hepato-metabolic assessment in MASLD.

Espervita Therapeutics, a biotechnology company developing targeted metabolic reprogramming therapies, announced the publication in Cell Metabolism of groundbreaking preclinical data demonstrating ...

Disclaimer: AlphaGalileo is not responsible for the accuracy of content posted to AlphaGalileo by contributing institutions or for the use of any information through the AlphaGalileo system.

Scientists have found that combining silybin with carvedilol works far better against liver fibrosis than either drug alone.

MetaVia Inc. (Nasdaq: MTVA), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced positive statistically significant results from the 8-week ...

.Net Ledger (NLedger) is a complete .Net port of the Ledger, an excellent powerful command line accounting system. The main purpose of this project is to enable all Ledger features to .Net world.

The study reveals that nicotinic acid (vitamin B3) significantly protects the liver during ischemia-reperfusion injury by ...

A research team reports a promising new strategy: combining two already-approved drugs—silybin, a natural liver-protective compound, and carvedilol, a widely used cardiovascular medicine—to powerfully ...

Jeremiah Raber, best known for his reality show \"Breaking Amish\", was reportedly recently airlifted to hospital with ...

Delcath Systems announces publication of subgroup analyses of phase 3 FOCUS study of Melphalan/Hepatic Delivery System in patients with unresectable metastatic uveal melanoma Queensbury, New York ...